Combining radioisotope tracing and blue patent modus was used for SLNB.
SLNB采用放射性示踪法和专利蓝法。
Objective: To study the feasibility of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy for breast cancer.
目的：探讨乳腺癌病人新辅助化疗后前哨淋巴结活检的可行性。
Combined techniques and pathologic ultrastaging may increase the identification rate and decrease the false negative rate in patients with SLNB.
采用生物活性染料- 放射性核素联合示踪法、病理连续切片及免疫组化染色可提高前哨淋巴结活检的检出率及准确性。
应用推荐